According to its instructions (1994:902), the Board is to promote
an ethically defensible and safe use of gene technology by the
provision of advice, so that the health of people and animals is
safeguarded. The Board shall in that connection take into
consideration the importance of maintaining a good research policy
The Board shall keep abreast of the national and international
developments in the field of gene technology, in order to be able
to evaluate the effect of new applications of gene technology on
health and the environment and to be able to make an ethical
assessment of new aspects of development.
The Board also has the task of disseminating knowledge about
developments in gene technology. It shall further notify the
Government if any area of use or planned area of use of gene
technology can be called into question from an ethical or
humanitarian point of view, or if the area for public supervision
needs to be expanded to include other matters than those at present
subject to public control.
The Board makes statements on applications for consent pursuant to
the Act concerning Genetically Modified Organisations and consults
the supervisory authorities when regulations are notified pursuant
to the act. The EEA agreement and membership of the EU also entail
that statements are made on applications for intentional placement
of genetically modified organisms and release on the market of such
products in other countries within the EU.